{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:19:58Z","timestamp":1793089198144,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016946","name":"Singulex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jchf.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T16:02:37Z","timestamp":1565193757000},"page":"782-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":199,"title":["Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in\u00a0Heart\u00a0Failure With Reduced\u00a0Ejection\u00a0Fraction"],"prefix":"10.1016","volume":"7","author":[{"given":"Alberto","family":"Aimo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna K.","family":"Gaggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Barison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Emdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2019.06.004_bib1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling\u2014concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. On behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib2","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4330\/wjc.v9.i6.470","article-title":"Cardiac damage in athlete's heart: When the \u201csupernormal\u201d heart fails!","volume":"9","author":"Carbone","year":"2017","journal-title":"World J Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCRESAHA.118.312017","article-title":"Metabolic coordination of physiological and pathological cardiac remodeling","volume":"123","author":"Gibb","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2019.06.004_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2019.06.004_bib6","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCIMAGING.113.000438","article-title":"Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study","volume":"6","author":"Masci","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2019.06.004_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijcard.2015.02.019","article-title":"Biomarker-assist score for reverse remodeling prediction in heart failure: the ST2-R2 score","volume":"184","author":"Lup\u00f3n","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.amjcard.2012.02.054","article-title":"Usefulness of left ventricular end-systolic dimension by echocardiography to predict reverse remodeling in patients with newly diagnosed severe left ventricular systolic dysfunction","volume":"110","author":"Bhat","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib9","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.jacc.2010.11.030","article-title":"Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment","volume":"57","author":"Merlo","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib10","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jocs.13190","article-title":"The impact of global left ventricular afterload on left ventricular reverse remodeling after aortic valve replacement","volume":"32","author":"Ito","year":"2017","journal-title":"J\u00a0Cardiac Surg"},{"key":"10.1016\/j.jchf.2019.06.004_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2010.05.011","article-title":"Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach","volume":"56","author":"Kramer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrcardio.2011.172","article-title":"Reverse remodeling in heart failure\u2014mechanisms and therapeutic opportunities","volume":"9","author":"Koitabashi","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2018.05.042","article-title":"Dynamic trajectories of left ventricular ejection fraction in heart failure","volume":"72","author":"Lupon","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ahj.2011.10.001","article-title":"Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF","volume":"163","author":"Wilcox","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2019.06.004_bib15","first-page":"735","article-title":"Effect of sex on reverse remodeling in chronic systolic heart failure","volume":"5","author":"Aimo","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2019.06.004_bib16","first-page":"52","article-title":"Reverse remodeling in dilated cardiomyopathy: insights and future perspectives","volume":"18","author":"Merlo","year":"2018","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jchf.2019.06.004_bib17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jacc.2015.07.023","article-title":"Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE(S) classification","volume":"66","author":"Hazebroek","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib18","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1136\/heartjnl-2016-311017","article-title":"Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy","volume":"103","author":"Dal Ferro","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2019.06.004_bib19","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.jacc.2012.01.065","article-title":"Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study","volume":"59","author":"Hsu","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ahj.2017.12.021","article-title":"Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril\/Valsartan Therapy for Heart\u00a0Failure (PROVE-HF)","volume":"199","author":"Januzzi","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2019.06.004_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ejechocard\/jer177","article-title":"Relationship between ultrasonic tissue characterization and myocardial deformation for prediction of left ventricular reverse remodelling in non-ischaemic dilated cardiomyopathy","volume":"12","author":"Park","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.jchf.2019.06.004_bib22","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2004.08.016","article-title":"Left ventricular dys-synchrony predicts response and prognosis after cardiac resynchronization therapy","volume":"44","author":"Bax","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib23","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/eurjhf\/hfr073","article-title":"Multicentre study using strain delay index for predicting response to cardiac resynchronization therapy (MUSIC study)","volume":"13","author":"Lim","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.06.004_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000246","article-title":"Mechanical dys-synchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure","volume":"2","author":"Bank","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.jchf.2019.06.004_bib25","first-page":"iii73","article-title":"Predicting response to CRT. The value of two- and three-dimensional echocardiography","volume":"10 Suppl 3","author":"Marsan","year":"2008","journal-title":"Europace"},{"key":"10.1016\/j.jchf.2019.06.004_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10741-015-9509-4","article-title":"Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance","volume":"20","author":"Barison","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jchf.2019.06.004_bib27","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s00380-016-0815-0","article-title":"Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy","volume":"31","author":"Ishii","year":"2016","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jchf.2019.06.004_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/heartjnl-2016-309746","article-title":"Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy","volume":"103","author":"Chimura","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2019.06.004_bib29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2017.10.043","article-title":"Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy","volume":"250","author":"Barison","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib30","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ijcard.2013.01.043","article-title":"Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol","volume":"168","author":"Kida","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib31","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ahj.2010.01.005","article-title":"Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart\u00a0Failure Therapy (PROTECT) study","volume":"159","author":"Bhardwaj","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2019.06.004_bib32","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib33","first-page":"158","article-title":"NT-proBNP goal achievement is associated with significant reverse remodeling and improved clinical outcomes in HFrEF","volume":"7","author":"Daubert","year":"2019","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2019.06.004_bib34","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/eurheartj\/ehl505","article-title":"Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dys-synchrony","volume":"28","author":"Fruhwald","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.06.004_bib35","first-page":"65","article-title":"Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure","volume":"2","author":"Gaggin","year":"2014","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2019.06.004_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12265-015-9618-4","article-title":"Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure","volume":"8","author":"Motiwala","year":"2015","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jchf.2019.06.004_bib37","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","article-title":"The IL-33\/ST2 pathway: therapeutic target and novel biomarker","volume":"7","author":"Kakkar","year":"2008","journal-title":"Nat Rev Drugs Discov"},{"key":"10.1016\/j.jchf.2019.06.004_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijcard.2015.11.163","article-title":"Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: a multicenter study","volume":"204","author":"Lupon","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib39","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1161\/CIRCULATIONAHA.104.508093","article-title":"Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction","volume":"111","author":"Solomon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.06.004_bib40","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/eurjhf\/hft056","article-title":"Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair","volume":"15","author":"Kortekaas","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.06.004_bib41","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/eurjhf\/hft075","article-title":"Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart\u00a0Failure Therapy (PROTECT) study","volume":"15","author":"Motiwala","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2019.06.004_bib42","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12265-013-9522-8","article-title":"Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling","volume":"7","author":"Motiwala","year":"2014","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.jchf.2019.06.004_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-319-22671-2_10","article-title":"microRNAs and cardiovascular remodeling","volume":"888","author":"Ono","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jchf.2019.06.004_bib44","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.jacc.2016.08.049","article-title":"Circulating concentrations of orexin A predict left ventricular myocardial remodeling","volume":"68","author":"Ibrahim","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib45","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/eci.12479","article-title":"Prognosis of new-onset heart failure outpatients and collagen biomarkers","volume":"45","author":"Sanchis","year":"2015","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.jchf.2019.06.004_bib46","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0735-1097(02)02337-9","article-title":"Cardiac resynchronization therapy tailored by echocardiographic evaluation of ventricular asynchrony","volume":"40","author":"Pitzalis","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib47","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1161\/CIRCULATIONAHA.107.743120","article-title":"Results of the predictors of response to CRT (PROSPECT) trial","volume":"117","author":"Chung","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2019.06.004_bib48","first-page":"264","article-title":"Influence of stentless versus stented valves on ventricular remodeling assessed at 6\u00a0months by magnetic resonance imaging and long-term follow-up","volume":"69","author":"Fouquet","year":"2017","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib49","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.jacc.2003.12.053","article-title":"Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: valsartan heart failure trial (Val-HeFT) echocardiographic data","volume":"43","author":"Wong","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/eurheartj\/ehv418","article-title":"Association of persistent or worsened echocardiographic dys-synchrony with unfavourable clinical outcomes in heart failure patients with narrow QRS width: a subgroup analysis of the EchoCRT trial","volume":"37","author":"Gorcsan","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.06.004_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ejechocard\/jer021","article-title":"Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography","volume":"12","author":"Mor-Avi","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.jchf.2019.06.004_bib52","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/eurheartj\/ehr391","article-title":"Effects of myocardial fibrosis and ventricular dys-synchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography","volume":"33","author":"Leong","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2019.06.004_bib53","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jacc.2012.07.072","article-title":"Novel predictors of left ventricular reverse remodeling in individuals with recent-onset dilated cardiomyopathy","volume":"61","author":"Kubanek","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2019.06.004_bib54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s00380-013-0415-1","article-title":"Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy","volume":"29","author":"Nabeta","year":"2014","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jchf.2019.06.004_bib55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.amjcard.2018.04.017","article-title":"Usefulness of addition of magnetic resonance imaging to echocardiographic imaging to predict left ventricular reverse remodeling in patients with nonischemic cardiomyopathy","volume":"122","author":"Merlo","year":"2018","journal-title":"Am J Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177919304743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177919304743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:51:46Z","timestamp":1761972706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177919304743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2213177919304743"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2019.06.004","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in\u00a0Heart\u00a0Failure With Reduced\u00a0Ejection\u00a0Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}